Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 11, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 5W9H | 5W9H | MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4 | |
| 5W9I | W5ZZF5 | MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4 | Spike glycoprotein, G4 VH, G4 VL |
| 5W9I | 5W9I | MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4 | Spike glycoprotein, G4 VH, G4 VL |
| 6PZ8 | W5ZZF5 | MERS S0 trimer in complex with variable domain of antibody G2 | |
| 6PZ8 | W6A090 | MERS S0 trimer in complex with variable domain of antibody G2 | |
| 6PZ8 | 6PZ8 | MERS S0 trimer in complex with variable domain of antibody G2 | |
| 8YSH | 8YSH | MERS-CoV RBD in complex with nanobody Nb14 | |
| 8YSH | R9UQ53 | MERS-CoV RBD in complex with nanobody Nb14 | |
| 7M5E | A0A140AYW5 | MERS-CoV S bound to the broadly neutralizing B6 Fab fragment (C3 refinement) | |
| 6NB4 | A0A140AYW5 | MERS-CoV S complex with human neutralizing LCA60 antibody Fab fragment (state 2) | |
| 6NB4 | 6NB4 | MERS-CoV S complex with human neutralizing LCA60 antibody Fab fragment (state 2) | |
| 6Q06 | K0BRG7 | MERS-CoV S structure in complex with 2,3-sialyl-N-acetyl-lactosamine | |
| 6Q07 | K0BRG7 | MERS-CoV S structure in complex with 2,6-sialyl-N-acetyl-lactosamine | |
| 6Q04 | K0BRG7 | MERS-CoV S structure in complex with 5-N-acetyl neuraminic acid | |
| 6Q05 | K0BRG7 | MERS-CoV S structure in complex with sialyl-lewisX | |
| 6NB3 | A0A140AYW5 | MERS-CoV complex with human neutralizing LCA60 antibody Fab fragment (state 1) | |
| 6NB3 | 6NB3 | MERS-CoV complex with human neutralizing LCA60 antibody Fab fragment (state 1) | |
| 6J11 | A0A2D0YPK3 | MERS-CoV spike N-terminal domain and 7D10 scFv complex | |
| 6J11 | 6J11 | MERS-CoV spike N-terminal domain and 7D10 scFv complex | |
| 8IFN | 8IFN | MERS-CoV spike trimer in complex with nanobody VHH-T148 | |
| 8IFN | R9UQ53 | MERS-CoV spike trimer in complex with nanobody VHH-T148 | |
| 1LFI | P02788 | METAL SUBSTITUTION IN TRANSFERRINS: THE CRYSTAL STRUCTURE OF HUMAN COPPER-LACTOFERRIN AT 2.1 ANGSTROMS RESOLUTION | |
| 1VXO | P04058 | METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) OBTAINED BY REACTION WITH O-ETHYL-S-[2-[BIS(1-METHYLETHYL)AMINO]ETHYL] METHYLPHOSPHONOTHIOATE (VX) | |
| 1CFJ | P04058 | METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) OBTAINED BY REACTION WITH O-ISOPROPYLMETHYLPHOSPHONOFLUORIDATE (GB, SARIN) | |
| 1QLF | P01899 | MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G | |
| 1QLF | P01884 | MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G | |
| 1QLF | P04857 | MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G | |
| 1FZK | P01901 | MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN | |
| 1FZK | P01887 | MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN | |
| 1FZK | P04857 | MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN | |
| 1FZJ | P01901 | MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN | |
| 1FZJ | P01887 | MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN | |
| 1FZJ | P11212 | MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN | |
| 1FZO | P01901 | MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN | |
| 1FZO | P01887 | MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN | |
| 1FZO | P04857 | MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN | |
| 1FZM | P01901 | MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN | |
| 1FZM | P01887 | MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN | |
| 1FZM | P11212 | MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN | |
| 1KBG | P01901 | MHC Class I H-2KB Presented Glycopeptide RGY8-6H-GAL2 | |
| 1KBG | P01887 | MHC Class I H-2KB Presented Glycopeptide RGY8-6H-GAL2 | |
| 1KBG | P11212 | MHC Class I H-2KB Presented Glycopeptide RGY8-6H-GAL2 | |
| 4P57 | P20036 | MHC TCR peptide complex | |
| 4P57 | Q5EP54 | MHC TCR peptide complex | |
| 4P57 | 4P57 | MHC TCR peptide complex | |
| 4P57 | Q5EP54 | MHC TCR peptide complex | |
| 4P57 | 4P57 | MHC TCR peptide complex | |
| 6XNG | P11609 | MHC-like protein complex structure | |
| 6XNG | P01887 | MHC-like protein complex structure | |
| 6XNG | 6XNG | MHC-like protein complex structure |
